Showing 2 posts of 2 posts found.
Many people in pharma would argue that the world of regulatory compliance in the life sciences industry is already complicated …
Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …
NHS England approves delayed-release treatment for rare kidney disease
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation